Acorah Software Products - Accounts Production 16.1.300 false true false true No description of principal activity 29 January 2024 31 January 2025 31 January 2025 13166822 Mr Matthew Buchan iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13166822 2024-01-28 13166822 2025-01-31 13166822 2024-01-29 2025-01-31 13166822 frs-core:CurrentFinancialInstruments 2025-01-31 13166822 frs-bus:PrivateLimitedCompanyLtd 2024-01-29 2025-01-31 13166822 frs-bus:FilletedAccounts 2024-01-29 2025-01-31 13166822 frs-bus:Micro-entities 2024-01-29 2025-01-31 13166822 frs-bus:AuditExempt-NoAccountantsReport 2024-01-29 2025-01-31 13166822 frs-bus:Director1 2024-01-29 2025-01-31
Registered number: 13166822
Matthew Buchan Clinical Coding Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2025
Whyfield Limited
Balance Sheet
Registered number: 13166822
2025
£
Fixed assets 3,473
Current assets 11,073
Creditors: Amounts Falling Due Within One Year (5,836 )
NET CURRENT ASSETS 5,237
TOTAL ASSETS LESS CURRENT LIABILITIES 8,710
Accruals and deferred income (1,125 )
NET ASSETS 7,585
CAPITAL AND RESERVES 7,585

Notes

1. General Information
Matthew Buchan Clinical Coding Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13166822 . The registered office is 28 Greenbank Close, Grampound Road, Truro, TR2 4TD.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Matthew Buchan
Director
25/03/2025